Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
BPC-157's Role BPC-157 promotes angiogenesis the formation of new blood vessels at injury sites
The human research is early but the preclinical literature is deep and consistent
This situation undermines the credibility of the reported outcomes and highlights the need for independent, peer-reviewed research
Seiwerth et al., 2018)
Anecdotal evidence from user communities provides additional perspective
WADA Prohibition The World Anti-Doping Agency classifies multiple components as prohibited substances: BPC-157: Listed under Section S0 (Non-Approved Substances), prohibited at all times TB-500: Listed under S2: Peptide Hormones, Growth Factors, prohibited at all times GHK-Cu: Not specifically prohibited but peptide combinations generally scrutinized KPV: Not explicitly listed but could fall under similar chemical structure provisions No Therapeutic Use Exemptions (TUEs) available for any prohibited components Combined formulations would fall under multiple prohibited categories Detection methods developed for BPC-157 (up to 4 days) and TB-500 WADAs prohibition reflects the lack of regulatory approval from health authorities worldwide for these peptides and concerns about tissue-regenerative and performance-enhancing properties
US$ 25.07
US$ 22.71
US$ 28.14
US$ 29.25
